Literature DB >> 19041298

Quantification of malonylcarnitine in dried blood spots by use of MS/MS varies by stable isotope internal standard composition.

Donald H Chace1, Timothy Lim, Christina R Hansen, Barbara W Adam, W Harry Hannon.   

Abstract

BACKGROUND: The utilization of MS/MS for the analysis of amino acids and acylcarnitines from dried blood spots (DBS) is routine in many newborn screening (NBS) laboratories. Recently, malonylcarnitine (C3DC) was shown to be elevated in the DBS of affected infants with malonic acidemia. Quantitative features were unknown, so that its measurement was an approximation. Synthesis of malonylcarnitine enabled both a study in the analytical characteristics of C3DC and a survey of its measurement in NBS laboratories.
METHODS: Malonylcarnitine was enriched in blood and spotted onto filter paper cards. The DBS were sent to several laboratories for analysis, and the results were returned to the Centers for Disease Control and Prevention (CDC) for evaluation. Reports included a description of the MS/MS method utilized.
RESULTS: A pilot proficiency survey shows a bimodal distribution of data from 98 laboratories. Analysis of proficiency data reveals the use of different stable isotope internal standards for quantification. Analysis of standard, labeled or unlabelled ((2)H(3)-octanoylcarnitine (C8), glutarylcarnitine (C5DC) and malonylcarnitine (C3DC) revealed significantly different ion detection values. Quantification in laboratories is based on the ratio of the metabolite in question to a reference stable isotope standard.
CONCLUSIONS: Quantification of metabolites depends upon the reference isotope standard utilized. Quantification requires describing the standards used for estimation of concentration (a pseudo-concentration) and a notation that includes a reference to the isotope standard used. This descriptive method will enable harmonization of data in screening laboratories.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19041298     DOI: 10.1016/j.cca.2008.10.035

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  5 in total

1.  Site-Specific and Degree-Controlled Alkyl Deuteration via Cu-Catalyzed Redox-Neutral Deacylation.

Authors:  Xukai Zhou; Tingting Yu; Guangbin Dong
Journal:  J Am Chem Soc       Date:  2022-05-25       Impact factor: 16.383

2.  Quantitative acylcarnitine determination by UHPLC-MS/MS--Going beyond tandem MS acylcarnitine "profiles".

Authors:  Paul E Minkler; Maria S K Stoll; Stephen T Ingalls; Janos Kerner; Charles L Hoppel
Journal:  Mol Genet Metab       Date:  2015-10-08       Impact factor: 4.797

3.  The stability of hexacosanoyl lysophosphatidylcholine in dried-blood spot quality control materials for X-linked adrenoleukodystrophy newborn screening.

Authors:  Christopher A Haynes; Víctor R De Jesús
Journal:  Clin Biochem       Date:  2014-10-12       Impact factor: 3.281

4.  Postanalytical tools improve performance of newborn screening by tandem mass spectrometry.

Authors:  Patricia L Hall; Gregg Marquardt; David M S McHugh; Robert J Currier; Hao Tang; Stephanie D Stoway; Piero Rinaldo
Journal:  Genet Med       Date:  2014-05-29       Impact factor: 8.822

5.  Harmonizing Newborn Screening Laboratory Proficiency Test Results Using the CDC NSQAP Reference Materials.

Authors:  Charles Austin Pickens; Maya Sternberg; Mary Seeterlin; Víctor R De Jesús; Mark Morrissey; Adrienne Manning; Sonal Bhakta; Patrice K Held; Joanne Mei; Carla Cuthbert; Konstantinos Petritis
Journal:  Int J Neonatal Screen       Date:  2020-09-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.